COONasdaqOphthalmic GoodsFiscal year ends October 31
COOPER COMPANIES, INC.
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 9, 2026
$58.16+0.22 (+0.38%)
Close on Oct 19, 2026
- Market cap
- $11.25B
- P/E (TTM)
- 19.8
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
65.5%+2.4 pts over 5 years
Operating margin
16.7%+3.9 pts over 5 years
Net margin
9.2%−0.6 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +5.1% | +7.3% | +11.0% | +8.6% | |
| Gross profit | +3.3% | +7.8% | +11.8% | +9.6% | |
| Operating income | -3.2% | +10.4% | +17.0% | +11.2% | |
| Net income | -4.4% | -1.0% | +9.5% | +6.3% | |
| EPS, diluted | -4.6% | -1.2% | +9.2% | +6.1% | |
| Free cash flow | +50.5% | -1.3% | +19.7% | +11.4% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 10.2% | 6.4% | 4.6% | |
| Return on assets | 6.1% | 3.7% | 3.0% | |
| Current ratio | 1.73 | 1.27 | 1.89 | |
| Debt to equity | 0.57 | 0.47 | 0.30 | |
| Net debt to EBITDA | 2.76× | – | 2.26× | |
| Interest coverage | 12.4× | 8.5× | 6.8× | |
| Inventory turnover | 1.9× | 1.7× | 1.7× | |
| Capex to revenue | 7.8% | 12.8% | 8.9% | |
| Diluted shares | 196M | 198M | 200M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Cooper Companies generated $3.54B from operations and spent $2.03B on capital expenditure, dividends and share buybacks. 80% of that went back into the business.
Generated
$3.54B
Used
$2.03B
Capital expenditure$1.63B80%Dividends$9.00M0%Share buybacks$393.40M19%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin9.2%
×Asset turnover0.33×
×Equity multiplier1.51×
=Return on equity, FY20254.6%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 9.2% | 0.33× | 1.51× | 4.6% |
| FY2024 | 10.1% | 0.32× | 1.53× | 5.0% |
| FY2023 | 8.2% | 0.31× | 1.57× | 4.0% |
| FY2022 | 11.7% | 0.31× | 1.49× | 5.5% |
| FY2021 | 100.8% | 0.36× | 1.52× | 54.7% |
| FY2020 | 9.8% | 0.37× | 1.75× | 6.4% |
| FY2019 | 17.6% | 0.43× | 1.79× | 13.5% |
| FY2018 | 5.5% | 0.46× | 1.69× | 4.3% |
| FY2017 | 17.4% | 0.46× | 1.59× | 12.7% |
| FY2016 | 13.9% | 0.44× | 1.67× | 10.2% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
5of 9 tests passed in fiscal 2025. Scores of 7 to 9 are usually read as strong.
- ProfitableNet income above zero$374.90M
- Cash generatingOperating cash flow above zero$796.10M
- Return on assets improvedROA up on the prior year3.4% → 3.0%
- Earnings backed by cashOperating cash flow above net income$796.10M vs $374.90M
- Less leverageLong-term debt to assets fell20.7% → 19.8%
- Better liquidityCurrent ratio rose1.91 → 1.89
- No dilutionShare count did not rise200M → 200M
- Gross margin improvedGross margin up on the prior year66.64% → 65.54%
- More efficientAsset turnover rose0.33 → 0.33